HLS Therapeutics Inc. (OTCMKTS:HLTRF) Short Interest Up 3,100.0% in March

HLS Therapeutics Inc. (OTCMKTS:HLTRF) was the recipient of a significant increase in short interest during the month of March. As of March 15th, there was short interest totalling 3,200 shares, an increase of 3,100.0% from the February 28th total of 100 shares. Based on an average daily volume of 100 shares, the short-interest ratio is presently 32.0 days.

HLS Therapeutics Stock Up 1.6 %

Shares of OTCMKTS:HLTRF traded up $0.05 on Thursday, reaching $3.20. 200 shares of the company’s stock were exchanged, compared to its average volume of 923. The business’s 50-day moving average is $2.85 and its two-hundred day moving average is $2.66. HLS Therapeutics has a fifty-two week low of $2.22 and a fifty-two week high of $4.00.

About HLS Therapeutics

HLS Therapeutics Inc, a specialty pharmaceutical company, acquires and commercializes pharmaceutical products in the specialty central nervous system and cardiovascular markets in Canada, the United States, and internationally. The company's product portfolio includes Clozaril, an atypical antipsychotic for management of symptoms of treatment-resistant schizophrenia; and Vascepa, an icosapent ethyl capsules for cardiovascular disease.